Additionally, Teva has debuted clonidine transdermal system, USE an AB-rated bioequivalent to Catapres-TTS
. The clonidine transdermal system is available in strengths of 0.2 mg per day, 0.2 mg per day and 0.3 mg per day, in cartons containing four systems/adhesive covers.
Teva's recent generic introductions include diazepam rectal gel (Diastat AcuDial), once weekly fluoxetine delayed-release capsules USP (Prozac weekly), clonidine transdermal system USP (Catapres-TTS
), venlafaxine HC1 ER capsules (Effexor XR), Gianvi drospirenone and ethinyl estradiol tablets (Yaz), valacyclovir HCl tablets (Valtrex), tamsulosin HCl capsules (Flomax), losartan potassium tablets USP (Cozaar), and losartan potassium and HCTZ tablets (Hyzaar).